Tocotrienol ether derivative as well as preparation method and application thereof
By synthesizing and optimizing the administration method tocotrienol ether derivatives, the problem of low bioavailability of vitamin E nanoformula is solved, and effective protection and hematopoietic recovery of the hematopoietic system caused by ionizing radiation is achieved.
Patent Information
- Application Number
- CN202410028593.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-01-08
- Publication Date
- 2025-07-08
AI Technical Summary
Existing vitamin E nanoformulations have limitations in improving bioavailability, and it is difficult to effectively protect or alleviate the damage to the hematopoietic system caused by ionizing radiation, especially the treatment of H-ARS is not effective.
A series of tocotrienol ether derivatives were designed and synthesized, and delta-T3H derivatives with higher G-CSF induction were prepared through esterification and reduction reactions, and the administration method was optimized to improve bioavailability, including subcutaneous injection.
δ-T3H derivatives significantly improve bioavailability, show stronger radiation protection, can significantly increase the production of G-CSF, promote hematopoietic recovery, improve the survival rate of mice and the regeneration of peripheral blood cells.